RecruitingNot ApplicableNCT06392334
Mast Cells and Its Proteases in COPD
The Role of Mast Cells and Its Proteases in Chronic Obstructive Pulmonary Disease
Sponsor
Voronezh N.N. Burdenko State Medical Academy
Enrollment
30 participants
Start Date
Jan 29, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Mast cells proteases such as chymase and tryptase will be studied in the tissue of small and large airways in COPD patients
Eligibility
Min Age: 20 YearsMax Age: 70 Years
Inclusion Criteria1
- \- COPD patients
Exclusion Criteria2
- Other lung diseases, tumors, pregnancy
- \-
Interventions
OTHERBiopsy
Biopsy of lung tissue
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06392334
Related Trials
Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong
NCT058250141 location
Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD
NCT073519291 location
High-intensity Resistance Training in Post-exacerbation COPD
NCT073024251 location
DUET Versus Standard Interface for Hypercapnic COPD Patients
NCT058290832 locations
Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery
NCT041367171 location